Among them, type 3 ILCs (ILC3s) play a central role in the etiology and disease severity of psoriasis, which was ascribed to the elevated number of IL-22- and IL-17 A/F-producing ILC3s induced by their expression of RORγt transcription factors in psoriatic skin and blood [106, 108–110]. Here, IL22 is linked to psoriasis.